News & Publications
REPLICATe IN THE NEWS
Explore recent company announcements, stories about our science, and media coverage.
06.19.26
Press Releases
Replicate Bioscience Awarded Grant to Advance srRNA Vaccine Candidates for Tuberculosis
01.08.26
Press Releases
Replicate Bioscience Awarded Grants to Develop New srRNA Vaccines for HIV and Malaria
12.16.25
Press Releases
Replicate Bioscience Appoints Kathy Fernando, Ph.D., as Chief Business Officer
12.04.25
Press Releases
Replicate Bioscience and Instituto Butantan Enter Collaborative Agreement to Develop and Commercialize Replicate’s Self-Replicating RNA (srRNA) Rabies Vaccine in Latin America
09.24.25
Press Releases
Replicate Bioscience Announces Publication of Promising New Phase 1 Durability Data for Its srRNA Vaccine Candidate RBI-4000
08.28.25
Press Releases
Replicate Bioscience Announces Partnership with Novo Nordisk to Unlock Self-Replicating RNA Therapies for Obesity and Diabetes
02.07.25
Press Releases
Replicate Bioscience Announces Publication of First-in-Human Data for Its Optimized srRNA Rabies Vaccine in Nature Communications
08.21.24
Press Releases
Replicate Bioscience to Participate in Upcoming Investor and Scientific Conferences